Association of BP variability with mortality among African Americans with CKD

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 5, 2013, Pages 731-738

  McMullan, Ciaran J ^a   Bakris, George L ^b   Phillips, Robert A ^c   Forman, John P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; METOPROLOL; RAMIPRIL; ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE VARIABILITY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PROTEINURIA; RISK; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFECTS; EPIDEMIOLOGY; ETHNOLOGY; HYPERTENSION; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DISEASE-FREE SURVIVAL; HUMANS; HYPERTENSION; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84877638344     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10131012     Document Type: Article

References (36)

1. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375: 895-905, 2010
2. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S: The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANES III, 1988 to 1994. Hypertension 57: 160-166, 2011
3. Di Iorio B, Pota A, Sirico ML, Torraca S, Di Micco L, Rubino R, Guastaferro P, Bellasi A: Blood pressure variability and outcomes in chronic kidney disease. Nephrol Dial Transplant 27: 4404-4410, 2012
4. Shimbo D, Newman JD, Aragaki AK, LaMonte MJ, Bavry AA, Allison M, Manson JE, Wassertheil-Smoller S: Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: Data from the Women's Health Initiative. Hypertension 60: 625-630, 2012
5. Kilpatrick ES, Rigby AS, Atkin SL: The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care 33: 2442-2447, 2010
6. Kawai T, Ohishi M, Kamide K, Onishi M, Takeya Y, Tatara Y, Oguro R, Yamamoto K, Sugimoto K, Rakugi H: The impact of visit-to-visit variability in blood pressure on renal function. Hy-pertens Res 35: 239-243, 2012
7. Gassman JJ, Greene T, Wright JT Jr, Agodoa L, Bakris G, Beck GJ, Douglas J, Jamerson K, Lewis J, Kutner M, Randall OS, Wang SR: Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol 14 [Suppl 2]: S154-S165, 2003
8. Wright JT Jr, Kusek JW, Toto RD, Lee JY, Agodoa LY, Kirk KA, Randall OS, Glassock R: Design and baseline characteristics of participants in the African American Studyof Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials 17[Suppl]: 3S-16S, 1996
9. Rossignol P, Cridlig J, Lehert P, Kessler M, Zannad F: Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: Insights from FOSIDIAL. Hypertension 60: 339-346, 2012
10. Mancia G, Facchetti R, Parati G, Zanchetti A: Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 126: 569-578, 2012
11. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K: Visit-to-visit blood pressure variations: New independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens 30: 1556-1563, 2012
12. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K: Visit-to-visit blood pressure variations: New independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 5: 184-192, 2011
13. Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K: Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 25: 962-968, 2012
14. Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT Jr, Wang X, Greene T, Appel LJ, Lewis J, Group AS; AASK Study Group: Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 48: 739-751, 2006
15. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S; African American Study of Kidney Disease and Hypertension (AASK) Study Group: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA 285: 2719-2728, 2001
16. Toto RD, Kirk KA, Coresh J, Jones C, Appel L, Wright J, Campese V, Olutade B, Agodoa L: Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: Results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. J Am Soc Nephrol 8: 279-287, 1997
17. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421-2431, 2002
18. Miao CY, Xie HH, Zhan LS, Su DF: Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 24: 1125-1135, 2006
19. Diaz KM, Veerabhadrappa P, Kashem MA, Feairheller DL, Sturgeon KM, Williamson ST, Crabbe DL, Brown MD: Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res 35: 55-61, 2012
20. Okada H, Fukui M, Tanaka M, Inada S, Mineoka Y, Nakanishi N, Senmaru T, Sakabe K, Ushigome E, Asano M, Yamazaki M, Hasegawa G, Nakamura N: Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 220: 155-159, 2012
21. Rothwell PM: Does blood pressure variability modulate cardiovascular risk? Curr Hypertens Rep 13: 177-186, 2011
22. Brenner BM, Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA: The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endo-crinol Suppl (Copenh) 242: 7-10, 1981
23. Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC: Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: A 5z5-year prospective analysis. Eur J Clin Invest 42: 245-253, 2012
24. Grove JS, Reed DM, Yano K, Hwang LJ: Variability in systolic blood pressure-a risk factor for coronary heart disease? Am J Epidemiol 145: 771-776, 1997
25. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Poulter NR, Sever PS; ASCOT-BPLA and MRC Trial Investigators: Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 9: 469-480, 2010
26. Chen SC, Chang JM, Liu WC, Wang CS, Su HM, Chen HC: Arterial stiffness in patients with chronic kidney disease. Am J Med Sci 343: 109-113, 2012
27. Chen SC, Chang JM, Tsai YC, Su HM, Chen HC: Brachial-ankle pulse wave velocity and brachial pre-ejection period to ejection time ratio with renal outcomes in chronic kidney disease. Hy-pertens Res 35: 1159-1163, 2012
28. Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P: Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes. Diabet Med 29: 990-994, 2012
29. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller ER 3rd, Randall O, Wang X, McClellan W, Investigators AS; AASK Study Investigators: Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 51: 732-740, 2008
30. Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, Toto RD, Wang X, Wright JT Jr, Greene TH: Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 59: 504-512, 2012
31. Kawai T, Ohishi M, Onishi M, Takeya Y, Ito N, Kato N, Yamamoto K, Kamide K, Rakugi H: Influence of renin angio-tensin system gene polymorphisms on visit-to-visit blood pressure variability in hypertensive patients. Am J Hypertens 25: 1249-1255, 2012
32. Titan SM, Pereira AC, Cunha RS, Herkenhoff FL, Mill JG, Krieger JE: Renin-angiotensin system polymorphisms interact with blood pressure in the determination of microalbuminuria in the general population. J Hum Hypertens 20: 235-237, 2006
33. Li Z, Snieder H, Su S, Harshfield GA, Treiber FA, Wang X: A longitudinal study of blood pressure variability in African-American and European American youth. J Hypertens 28: 715-722, 2010
34. Jehn ML, Brotman DJ, Appel LJ: Racial differences in diurnal blood pressure and heart rate patterns: Results from the Dietary Approaches to Stop Hypertension (DASH) trial. Arch Intern Med 168: 996-1002, 2008
35. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R; AASK Pilot Study Investigators: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A reportfrom the African AmericanStudyof KidneyDisease (AASK) Trial. Kidney Int 51: 244-252, 1997
36. Wright JT Jr, Agodoa L, Contreras G, Greene T, Douglas JG, Lash J, Randall O, Rogers N, Smith MC, Massry S; African American Study of Kidney Disease and Hypertension Study Group: Successful blood pressure control in the African American Study of Kidney Disease and Hypertension. Arch Intern Med 162: 1636-1643, 2002